New York Times, November 19, 2008

A federal appeals court in Boston has dealt a setback to the pharmaceutical industry and companies that collect prescription data for use in drug marketing. The court upheld the right of states to prohibit the sale of doctor-specific prescription drug data that is widely used in pharmaceutical marketing. IMS Health and Verispan sued to block implementation of a New Hampshire law which prohibited the sale of computerized data showing which doctors were prescribing what drugs.

Facebook icon
LinkedIn icon
Twitter icon